Previous studies reported that FL SPARC and particularly its C-terminal extracellular Ca2+ binding domain can modulate adhesion, spreading, motility, endothelial transmigration, and invasion of cancer and stromal cells 25, 26, 33, 47-49. This evidence concerns the gene SPARC and cancer.